These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 20043850

  • 1. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
    Dong L, Jensen RV, De Rienzo A, Gordon GJ, Xu Y, Sugarbaker DJ, Bueno R.
    BMC Med Genet; 2009 Dec 31; 10():149. PubMed ID: 20043850
    [Abstract] [Full Text] [Related]

  • 2. Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.
    Suraokar MB, Nunez MI, Diao L, Chow CW, Kim D, Behrens C, Lin H, Lee S, Raso G, Moran C, Rice D, Mehran R, Lee JJ, Pass HI, Wang J, Momin AA, James BP, Corvalan A, Coombes K, Tsao A, Wistuba II.
    Ann Oncol; 2014 Jun 31; 25(6):1184-92. PubMed ID: 24669013
    [Abstract] [Full Text] [Related]

  • 3. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
    Cheng YY, Wright CM, Kirschner MB, Williams M, Sarun KH, Sytnyk V, Leshchynska I, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, van Zandwijk N, Lin RC, Reid G.
    Mol Cancer; 2016 Jun 01; 15(1):44. PubMed ID: 27245839
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.
    Alì G, Borrelli N, Riccardo G, Proietti A, Pelliccioni S, Niccoli C, Boldrini L, Lucchi M, Mussi A, Fontanini G.
    J Thorac Oncol; 2013 Nov 01; 8(11):1389-95. PubMed ID: 24084442
    [Abstract] [Full Text] [Related]

  • 5. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
    Cheng YY, Kirschner MB, Cheng NC, Gattani S, Klebe S, Edelman JJ, Vallely MP, McCaughan BC, Jin HC, van Zandwijk N, Reid G.
    J Thorac Oncol; 2013 Oct 01; 8(10):1317-28. PubMed ID: 24457242
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
    Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T, Dong YW, Rozsas A, Kenessey I, Szirtes I, Grusch M, Jakopovic M, Samarzija M, Brcic L, Kern I, Rozman A, Popper H, Zöchbauer-Müller S, Heller G, Altenberger C, Ziegler B, Klepetko W, Berger W, Dome B, Hegedus B.
    J Pathol; 2015 Oct 01; 237(2):203-14. PubMed ID: 26011651
    [Abstract] [Full Text] [Related]

  • 7. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L, Tounsi A, Berenguer-Daizé C, Dussault N, Delfino C, Benyahia Z, Cayol M, Mabrouk K, Garcia S, Martin PM, Barlesi F, Ouafik L.
    J Thorac Oncol; 2016 Jan 01; 11(1):94-107. PubMed ID: 26762744
    [Abstract] [Full Text] [Related]

  • 8. Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
    De Rienzo A, Richards WG, Yeap BY, Coleman MH, Sugarbaker PE, Chirieac LR, Wang YE, Quackenbush J, Jensen RV, Bueno R.
    Clin Cancer Res; 2013 May 01; 19(9):2493-502. PubMed ID: 23493352
    [Abstract] [Full Text] [Related]

  • 9. Transcriptome sequencing of the Microarray Quality Control (MAQC) RNA reference samples using next generation sequencing.
    Mane SP, Evans C, Cooper KL, Crasta OR, Folkerts O, Hutchison SK, Harkins TT, Thierry-Mieg D, Thierry-Mieg J, Jensen RV.
    BMC Genomics; 2009 Jun 12; 10():264. PubMed ID: 19523228
    [Abstract] [Full Text] [Related]

  • 10. A comprehensive study of alternative splicing in malignant pleural mesothelioma identifies potential therapeutic targets in a new cluster with poor survival.
    Shao MM, Qiao X, Chen QY, Yi FS.
    Thorac Cancer; 2022 Aug 12; 13(16):2318-2330. PubMed ID: 35790883
    [Abstract] [Full Text] [Related]

  • 11. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
    Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, Davies C, Williams A, Turpaz Y.
    BMC Genomics; 2006 Dec 27; 7():325. PubMed ID: 17192196
    [Abstract] [Full Text] [Related]

  • 12. RNA sequencing and transcriptome arrays analyses show opposing results for alternative splicing in patient derived samples.
    Nazarov PV, Muller A, Kaoma T, Nicot N, Maximo C, Birembaut P, Tran NL, Dittmar G, Vallar L.
    BMC Genomics; 2017 Jun 06; 18(1):443. PubMed ID: 28587590
    [Abstract] [Full Text] [Related]

  • 13. A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.
    Melaiu O, Cristaudo A, Melissari E, Di Russo M, Bonotti A, Bruno R, Foddis R, Gemignani F, Pellegrini S, Landi S.
    Mutat Res; 2012 Jun 06; 750(2):132-140. PubMed ID: 22198210
    [Abstract] [Full Text] [Related]

  • 14. Transcriptome sequencing of malignant pleural mesothelioma tumors.
    Sugarbaker DJ, Richards WG, Gordon GJ, Dong L, De Rienzo A, Maulik G, Glickman JN, Chirieac LR, Hartman ML, Taillon BE, Du L, Bouffard P, Kingsmore SF, Miller NA, Farmer AD, Jensen RV, Gullans SR, Bueno R.
    Proc Natl Acad Sci U S A; 2008 Mar 04; 105(9):3521-6. PubMed ID: 18303113
    [Abstract] [Full Text] [Related]

  • 15. Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
    Bruno R, Alì G, Giannini R, Proietti A, Lucchi M, Chella A, Melfi F, Mussi A, Fontanini G.
    Oncotarget; 2017 Jan 10; 8(2):2758-2770. PubMed ID: 27835874
    [Abstract] [Full Text] [Related]

  • 16. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
    Gordon GJ, Rockwell GN, Jensen RV, Rheinwald JG, Glickman JN, Aronson JP, Pottorf BJ, Nitz MD, Richards WG, Sugarbaker DJ, Bueno R.
    Am J Pathol; 2005 Jun 10; 166(6):1827-40. PubMed ID: 15920167
    [Abstract] [Full Text] [Related]

  • 17. EasyCluster2: an improved tool for clustering and assembling long transcriptome reads.
    Bevilacqua V, Pietroleonardo N, Giannino E, Stroppa F, Simone D, Pesole G, Picardi E.
    BMC Bioinformatics; 2014 Jun 10; 15 Suppl 15(Suppl 15):S7. PubMed ID: 25474441
    [Abstract] [Full Text] [Related]

  • 18. MicroRNAs dysregulation in human malignant pleural mesothelioma.
    Balatti V, Maniero S, Ferracin M, Veronese A, Negrini M, Ferrocci G, Martini F, Tognon MG.
    J Thorac Oncol; 2011 May 10; 6(5):844-51. PubMed ID: 21358347
    [Abstract] [Full Text] [Related]

  • 19. Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.
    Ramírez-Salazar EG, Salinas-Silva LC, Vázquez-Manríquez ME, Gayosso-Gómez LV, Negrete-Garcia MC, Ramírez-Rodriguez SL, Chávez R, Zenteno E, Santillán P, Kelly-García J, Ortiz-Quintero B.
    Exp Mol Pathol; 2014 Dec 10; 97(3):375-85. PubMed ID: 25236577
    [Abstract] [Full Text] [Related]

  • 20. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.
    Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Ramaswamy S, Richards WG, Sugarbaker DJ, Bueno R.
    Cancer Res; 2002 Sep 01; 62(17):4963-7. PubMed ID: 12208747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.